Tags: Drug.
Taspoglutide is a pharmaceutical drug a glucagon-like peptide-1 agonist (GLP-1 agonist) under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.Two phase II trials reported it was effective and well tolerated.Of the eight planned phase III clinical trials of weekly taspoglutide (four against exenatide sitagliptin insulin glargine and pioglitazone) at least five were active in 2009. Preliminary results in early 2010 were favourable.